Active Pharmaceutical Ingredient Market

Global Active Pharmaceutical Ingredient (API) Market Is Estimated To Witness High Growth Owing To Increasing Drug Research and Development


The global Active Pharmaceutical Ingredient (API) Market is estimated to be valued at USD 206.0 billion in 2021 and is expected to exhibit a CAGR of 6.8% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

The Active Pharmaceutical Ingredient (API) market refers to the chemical compound or substance that is responsible for the therapeutic effect in a drug. APIs are the key ingredients in pharmaceutical products that provide the desired pharmacological activity. These ingredients play a crucial role in the efficacy, safety, and quality of a drug. APIs can be synthesized through various processes such as chemical synthesis, fermentation, and biotechnology processes. The increasing prevalence of chronic diseases and the growing demand for affordable and personalized medicine are driving the growth of the API market.

B) Market key trends:

One key trend in the API market is the increasing focus on drug research and development. Pharmaceutical companies are investing heavily in R&D activities to develop innovative drugs that cater to the unmet medical needs of patients. This is driven by factors such as the rising incidence of chronic diseases, aging population, and advancements in technology. For example, Pfizer Inc., one of the key players in the API market, invested USD 8.3 billion in R&D activities in 2020. This trend is expected to drive the demand for APIs as they are essential for drug development.

C) PEST Analysis:

– Political: Government regulations and policies affect the pharmaceutical industry, including APIs. Stringent regulations regarding drug manufacturing and quality control impact API manufacturers.

– Economic: The economic factors such as healthcare expenditure, GDP growth, and disposable income of individuals influence the demand for APIs.

– Social: The increasing prevalence of chronic diseases and the growing geriatric population create a higher demand for pharmaceutical products, thereby driving the API market.

– Technological: Technological advancements in drug discovery and development, such as high-throughput screening techniques and computer-aided drug design, are driving the API market.

D) Key Takeaways:

  1. The global API market is expected to witness high growth, exhibiting a CAGR of 6.8% over the forecast period, due to increasing drug research and development. Active Pharmaceutical Ingredient (API) Market play a critical role in the efficacy and safety of drugs, driving their demand.
  2. North America is the fastest-growing and dominating region in the API market, attributed to the presence of key players, robust healthcare infrastructure, and increasing R&D activities.
  3. Key players operating in the global API market include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Novartis AG, Mylan N.V., and others. These players are investing in R&D activities and strategic collaborations to strengthen their market position.

In conclusion, the global API market is poised for significant growth driven by increasing drug research and development activities. The market’s growth potential is fueled by factors such as rising chronic diseases, technological advancements, and favorable government regulations. The key players in the market are focusing on innovation and collaborations to capitalize on emerging opportunities in the API industry.